Recipharm

Ascertaining drug stability is an essential step of the product development process and must be performed in accordance with strict regulatory requirements. In this webinar, Recipharm present the guidance provided by the ICH to help support companies in maintaining a rigorous approach to stability testing, and detail what it takes to meet its requirements.

https://www.pharmtech.com/pt/otc-products

Stability testing is an essential step in the product development process and a mandatory requirement in the life cycle of a treatment. The International Council on Harmonisation - Quality (ICH Q1A) guidance exists to support companies in maintaining a rigorous approach to stability testing. This webinar will explore the detail of ICH Q1A and explain how to meet its requirements.

Understand the different stability requirements for each drug product type

Learn about the critical stability requirements for your consumer healthcare products

Understand the key benefits of working with an expert stability study partner

Understand what needs to be considered to run a major stability program successfully


Formulation Scientist, Production Manager, Senior Vice President Production, Director of Production Operations, Director of Manufacturing, Vice President of Global Supply Chain, Head of Supply Chain Management, Senior Vice President Supply Chain, Supply Manager, Vice President Project, Director of Procurement, Development Manager, Head of Production, Formulation Chemist, Vice President Global Procurement, Director of Development, Project Director, Vice President of Production, Vice President of Manufacturing, Chief Operating Officer, Head of Procurement, Vice President Supply Chain, Project Manager, Head of Product Development, Senior Project Director, Senior Category Manager, Supply Chain Manager, Category Manager, Supply Director, Vice President Procurement, Category Development Manager, Director of Project Development, Category Director, Procurement Manager, Production Director, Manufacturing Manager, Senior Project Manager, Vice President of Development, Chief Executive Officer, Chief Scientific Officer, Head of Manufacturing, Director Project Operations, Head of Development, Mid-sized and big pharma companies, Phase 3 and commercial phase buyers


Asst. Vice President, Analytical Development
Recipharm

 has a Ph.D. in Pharmaceutical Analysis and is currently heading the Analytical Centre of Excellence at Recipharm, Bengaluru, India. He has 22 years of experience in analytical research and development. He has authored numerous research publications in the areas of analytical development, analytical validation, controlled release technology and stability studies. He is an expert in stability studies for NCE, ANDA, commercial and clinical stability.


Webcasts

Webinar Date/Time: Tue, Jan 31, 2023 11:00 AM EST

Ensuring Stability Excellence for Global Consumer and OTC Products

Bespak by Recipharm delivers market leading design, development, and manufacture of drug delivery devices to the global pharmaceutical market. This includes inhaler, nasal technologies, and auto-injectors as well as development and manufacturing services.

Bespak by Recipharm is at the leading edge of drug delivery device innovation. Driven by customer and patient demand, our innovations have the potential to create new treatments and opportunities across the globe as well as accelerating routes to market.

Our customers include some of the world’s largest pharmaceutical companies where we work to optimise world-class drug delivery device development and manufacture, streamlined to accelerate our pharmaceutical customers’ drug route to market.

Bespak by Recipharm’s inhaler and nasal technologies expertise forms part of Recipharm Inhalation Solutions™, an end-to-end solution spanning early phase development to commercial manufacture of both inhalation drug product and device.

For more information about Bespak by Recipharm and our services, please visit 

For more information about Recipharm Inhalation Solutions™ please visit 

recipharm.com/solutions/recipharm-inhalation-solutions

Articles

Bespak by Recipharm delivers market leading design, development, and manufacture of drug delivery devices to the global pharmaceutical market. 

Bespak by Recipharm

Getting a drug product to market can be a challenging process with lots to consider, but Recipharm’s team of experts is here to support you.

Recipharm is a leading contract development and manufacturing organization (CDMO) headquartered in Stockholm, Sweden. We operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US and are continuing to grow and expand our offering for our customers.

We deliver a wide range of GMP-compliant services from our dedicated and flexible development facilities, and have been continually innovating and developing new technologies and processes for over 20 years.

A streamlined drug development process with input from experienced scientists is essential to avoiding pitfalls early in the drug development process and progressing a compound to the clinic. We take a holistic view when developing your product and give you access to a wealth of process development and production expertise that complements our manufacturing services.

Contact Recipharm today to discover how we can support you to achieve drug development success.

Ensure the success of your drug development program with Recipharm. We have the expertise and capability to support your drug development project from the early stages through to manufacturing.